期刊文献+

固表定喘法联合匹多莫德治疗儿童哮喘的临床研究 被引量:9

Clinical study on the therapy for childhood asthma with Gubiqiaodingchuan method combined with pidotimod
暂未订购
导出
摘要 目的探讨固表定喘法联合匹多莫德治疗儿童哮喘的临床疗效及其对哮喘患儿肺功能和免疫功能的影响。方法将105例发作期哮喘患儿随机分为治疗组和对照组,治疗组55例采用固表定喘法联合匹多莫德治疗,对照组50例采用静脉给予抗感染对症药物治疗。观察2组治疗有效率、1 a内复发次数、肺功能及免疫功能的变化情况。结果 2组治疗后均有效、肺功能均有改善,但治疗组的有效率和肺功能改善情况均明显优于对照组(P均<0.05)。治疗组治疗后1 a内复发次数和免疫功能情况亦均有明显改善(P均<0.05),而对照组治疗前后无显著变化。结论固表定喘法联合匹多莫德能有效地缓解发作期哮喘患儿的症状、并能减少其复发次数、改善其肺功能及免疫功能情况,具有很好的远期疗效。 Objective It is to study the clinical efficacy of Gubiaodingchuan method combined with pidotimod on childhood asthma,and to explore its effects on pulmonary function and immune function in asthmatic children.Methods 105 cases of children with asthma in onset period were randomly divided into treatment group and control group.The treatment group with 55 cases were treated with gubiaodingchuan method combined with pidotimod,and the control group with 50 cases were given intravenous anti-infective and symptomatic therapy.The efficient rate,recurrence times within a year,the change of lung function and immune function were observed in both groups.Results After treatment,the therapy was effective,and lung function were improved in both groups,but the treatment group's efficiency and lung function improvement was better than that of the control group(P0.05).Within one year after treatment,recurrence times and immune function of treatment group had significantly improved(P0.05),while no signficant changes was found in the control group before and after treatment.Conclusion Gubiaodingchuan method combined with poditimod can effectively relieve the symptoms of children with asthma exacerbation,and reduce the recurrence times,improve lung function and immune function,so it has a good long term efficacy.
出处 《现代中西医结合杂志》 CAS 2012年第2期131-133,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 固表定喘法 儿童哮喘 匹多莫德 Gubiaodingchuan method childhood ashtma poditimod
  • 相关文献

参考文献6

二级参考文献10

  • 1许敏兰,陶芳标.儿童哮喘的全球流行及影响因素[J].国外医学(妇幼保健分册),2005,16(3):161-163. 被引量:34
  • 2王本样.现代中药药理学[M].天津科学技术出版社,1997.633.
  • 3廖福龙 李文 黄深 等.大鼠血栓形成速率的评定与正常值[J].生理科学,1984,4(5):143-143.
  • 4[4]Nemere I. Nongenomic Effecta of 1.25-dihydroxyvitamin D3: Potential Relation of a Plasmalemmal Receptor to the Acute Enhancement of Intestina ICalcium Transport in Chick[J] .J Nutr, 1995,125:1695~ 1698.
  • 5[5]Ninomiya I, Yonemura Y, Matsumoto H, et al. Expression of C-myc Gene Product in Gastric Carcinoma[J]. Oncology, 1991,48(1) :149~153.
  • 6徐叔云,药理实验方法学,1982年,841页
  • 7王本祥,现代中药药理学,1997年,58页
  • 8廖福龙,生理科学进展,1984年,4卷,5,6期,143页
  • 9中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
  • 10中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3563

共引文献2927

同被引文献47

  • 1李慧,王永军,孙进.匹多莫德及其制剂的研究进展[J].中国药剂学杂志(网络版),2012(4):68-73. 被引量:30
  • 2尤黎明,吴英.内科护理学[M].5版.北京:人民卫生出版社,2012.
  • 3Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals:a longitudinal cohortstudy[J]. Lancet, 2002,359(9309) :831-834.
  • 4Holgate S,Bisgaard H,Bjermer L,et al. The Brussels De- claration: the need for change in asthma management[J]. Eur Respir J,2008,32(6) :1433 1442.
  • 5Giagulli C, Noerder M, Avolio M, et al. Pidotimod pro- motes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level[J]. Int Im munopharmacol, 2009,9(12) : 1366-1373.
  • 6Holt PG, Strickland DH, Sly PD. Virus infection and al lergy in the development of asthma what is the connec tion? [J]. Curr Opin Allergy Clin Immunol,2012,12(2) 151-157.
  • 7Holgate ST, Arshad HS, Roberts GC, et al. A new look at the pathogenesis of asthma[J]. Clin Sci(Lond), 2009,118 (7) :439-450.
  • 8Simon MR,Chinchilli VM, Phillips BR, et al. Forced ex- piratory {low between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with nor- real FEV1 values[J]. J Allergy Clin Immunol, 2010, 126 (3) : 527-534.
  • 9Riboldi P, Gerosa M, Meroni PL. Pidotimod : a reappraisal [J]. lnt J Immunopathol Pharmaeol, 2009,22 (2): 255- 262.
  • 10Vagas Correa JB, Espinosa Morales S, Bolanos Ancona JC, et al. Pidotimod in recurring respiratory infection in children with allergic rhinitis,asthma,or both conditions[J]. Rev AI- erg Mex,2002,49(2) :27-32.

引证文献9

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部